Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jul. 31, 2022
Oct. 31, 2021
Current assets:    
Cash and cash equivalents $ 24,254 $ 29,128
Short-term investments 7,410 6,599
Prepaid expenses and other current assets 676 276
Total current assets 32,340 36,003
Operating lease right-of-use asset 223 254
Total assets 32,563 36,257
Current liabilities:    
Accounts payable 227 136
Accrued expenses 1,198 1,095
Operating lease liability 44 39
Total current liabilities 1,469 1,270
Operating lease liability, non-current 187 220
Total liabilities 1,656 1,490
Commitments and contingencies (Note 9)  
Shareholders’ equity:    
Preferred stock
Common stock, par value $.01 per share; 100,000,000 shares authorized; 30,653,418 and 30,050,894 shares issued and outstanding as of July 31, 2022 and October 31, 2021, respectively 307 301
Additional paid-in capital 246,303 239,927
Accumulated deficit (214,909) (204,790)
Total shareholders’ equity 31,701 35,438
Noncontrolling interest (Note 1) (794) (671)
Total equity 30,907 34,767
Total liabilities and equity 32,563 36,257
Series A Convertible Preferred Stock [Member]    
Shareholders’ equity:    
Preferred stock